newsfilter
← Latest News
ACCESS Newswire·

Midatech Pharma PLC Announces IND Application for MTX110 Study in GBM Effective

Investigational New Drug Application for Study of MTX110 in Recurrent Glioblastoma (GBM) Becomes Effective ABINGDON, OXFORDSHIRE / ACCESSWIRE / December 13, 2021 / Midatech Pharma PLC (AIM:MTPH)(NASDAQ:MTP), a drug delivery technology company focused on